Abstract:Background: Allergic inflammation has long been implicated in asthmatic hyperresponsiveness of airway smooth muscle (ASM), but its underlying mechanism remains incompletely understood. Serving as G protein-coupled receptor agonists, several inflammatory mediators can induce membrane depolarization, contract ASM, and augment cholinergic contractile response. We hypothesized that the signal cascade integrating on membrane depolarization by the mediators might involve asthmatic hyperresponsiveness. Objective: We sought to investigate the signaling transduction of inflammatory mediators in ASM contraction and assess its contribution in the genesis of hyperresponsiveness. Methods: We assessed the capacity of inflammatory mediators to induce depolarization currents by electrophysiological analysis. We analyzed the phenotypes of transmembrane protein 16A (TMEM16A) knockout mice, applied pharmacological reagents, and measured the Ca2+ signal during ASM contraction. To study the role of the depolarization signaling in asthmatic hyperresponsiveness, we measured the synergistic contraction by methacholine and inflammatory mediators both ex vivo and in an ovalbumin-induced mouse model. Results: Inflammatory mediators, such as 5-hydroxytryptamin, histamine, U46619, and leukotriene D-4, are capable of inducing Ca2+-activated Cl-currents in ASM cells, and these currents are mediated by TMEM16A. A combination of multiple analysis revealed that a G protein-coupled receptor-TMEM16-Avoltage-dependent Ca2+ channel signaling axis was required for ASM contraction induced by inflammatory mediators. Block of TMEM16A activity may significantly inhibit the synergistic contraction of acetylcholine and the mediators and hence reduces hypersensitivity. Conclusions: A G protein-coupled receptor-TMEM16-Avoltage-dependent Ca2+ channel axis contributes to inflammatory mediator-induced ASM contraction and synergistically activated TMEM16A by allergic inflammatory mediators with cholinergic stimuli.

Increased β2-adrenoceptor phosphorylation in airway smooth muscle in severe asthma: possible role of mast cell-derived growth factors

Phosphodiesterases Inhibition by Bacilli Calmette-Guérin Contributes to Decrease Asthma in Allergic Rats

Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors

β2-Adrenoceptor signaling in airway epithelial cells promotes eosinophilic inflammation, mucous metaplasia, and airway contractility

Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis

Extracellular Adenosine Diphosphate Stimulates CXCL10-Mediated Mast Cell Infiltration Through P2Y1 Receptor to Aggravate Airway Inflammation in Asthmatic Mice

HB-EGF–Promoted Airway Smooth Muscle Cells and Their Progenitor Migration Contribute to Airway Smooth Muscle Remodeling in Asthmatic Mouse

Inflammatory Mediators Mediate Airway Smooth Muscle Contraction Through a G Protein-Coupled Receptor–transmembrane Protein 16A–voltage-Dependent Ca2+ Channel Axis and Contribute to Bronchial Hyperresponsiveness in Asthma

Mechanisms of Mast Cell Activation in Severe Asthma: Beyond IgE

Reduced suppressive effect of β2-adrenoceptor agonist on fibrocyte function in severe asthma

PAF-induced airways hyperreactivity is modulated by mast cells in mice

Regulation of the inflammatory response in asthma by mast cell products

BET bromodomains regulate transforming growth factor-β-induced proliferation and cytokine release in asthmatic airway smooth muscle

IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk

Pharmacological ablation of the airway smooth muscle layer-Mathematical predictions of functional improvement in asthma

Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling

Integrin α2β1 regulates collagen I tethering to modulate hyperresponsiveness in reactive airway disease models

House dust mite allergens induce Ca2+ signalling and alarmin responses in asthma airway epithelial cells

N-cadherin antagonism is bronchoprotective in severe asthma models

Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors

The Overexpression of Heparin-Binding Epidermal Growth Factor Is Responsible for Th17-Induced Airway Remodeling in an Experimental Asthma Model